期刊文献+

2型糖尿病合并非酒精性脂肪肝临床分析 被引量:5

Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
下载PDF
导出
摘要 目的分析非酒精性脂肪肝(NAFLD)与2型糖尿病(T2DM)患者临床指标及血管病变的关系。方法选取住院T2DM患者214例,根据肝脏B超结果分为NAFLD组(合并NAFLD,n=116)和非NAFLD组(未合并NAFLD,n=98),回顾性分析2组患者的临床指标和血管病变发生情况。结果 NAFLD组较非NAFLD组体质指数(BMI),收缩压(SBP)、舒张压(DBP),血三酰甘油(TG)、γ-谷氨酰转移酶(GGT)、丙氨酸氨基转移酶(ALT)显著增高(P<0.05或P<0.01);Logistic多元回归分析显示SBP、TG、GGT是NAFLD的独立危险因素(P<0.05或P<0.01);NAFLD组大血管和微血管病变发生率显著高于非NAFLD组(P<0.05或P<0.01)。结论合并NAFLD的T2DM患者有明显的代谢综合征表现及肝酶升高,且糖尿病大血管和微血管病变发生率明显升高。 Objective To analyze the relationship of nonalcoholic fatty liver disease(NAFLD) to clinical parameters and vascular lesion in patients with type 2 diabetes mellitus(T2DM).Methods According to the results of ultrasound examination,214 hospitalized patients with T2DM were divided into NAFLD group(n=116) and non-NAFLD group(n=98).Clinical parameters and vascular lesion of patients were analyzed retrospectively.Results Compared with non-NAFLD group,NAFLD significantly increased body mass index(BMI),systolic blood pressure(SBP),diastolic blood pressure(DBP),levels of triglyceride(TG),γ-glutamyltransferase(GGT)and alanine aminotransferase(ALT),and incidence of macrovascular and microvascular disease(P0.05 or P0.01).Logistic regression analysis showed that SBP,TG and GGT were the independent risk factors for NAFLD(P0.05 or P0.01).Conclusion T2DM patients with NAFLD have obvious metabolic syndrome with elevated liver enzymes and macrovascular and microvascular complications.
出处 《南昌大学学报(医学版)》 CAS 2013年第3期39-41,57,共4页 Journal of Nanchang University:Medical Sciences
基金 南昌市科技局项目(洪科发计字〔2009〕72号)
关键词 2型糖尿病 非酒精性脂肪肝 大血管病变 微血管病变 type 2 diabetes mellitus nonalcoholic fatty liver disease macrovascular disease microvascular disease
  • 相关文献

参考文献19

  • 1Marchesini G, Brizi M, Eianchi G, et al. Nonalcoholic fatty liver disease a feature of the metabolic[J]. Diabetes, 2001,50 : 1844- 1850.
  • 2Bruno G, Merletti F, Biggeri A, et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 di- abetes: the casale monferrato study [J 1- Diabetes Care, 2004, 27 : 2689-2694.
  • 3Parvanova A I, Trevisan R, Iliev I P, et al. Insulin resistance and microalbuminuria: a crosssectional, case control study of 158 patients with type 2 diabetes and different degrees of uri- nary albumin excretion[J]. Diabetes, 2006,55 (5) ; 1486-1462.
  • 4中华医学会肝脏病学分会脂肪肝和酒精性脂肪肝病学组.非酒精性脂肪性肝病诊疗指南[J].热带医学杂志,2011,11(1):65-67.
  • 52007年版中国2型糖尿病防治指南[J].中华内分泌代谢杂志,2008,24(2). 被引量:267
  • 6李伟,向红丁,戴为信,萧新华,夏维波,伍学焱,冯凯.2型糖尿病患者非酒精性脂肪肝及其相关因素的临床分析[J].中国糖尿病杂志,2006,14(1):35-36. 被引量:23
  • 7范建高,朱军,李新建,李锐,戴菲,宋晓敏,陈兰,李锋,陈世耀.上海市成人脂肪肝患病率及其危险因素流行病学调查[J].中华肝脏病杂志,2005,13(2):83-88. 被引量:582
  • 8金春花,范能光,张文,刘建华,夏振华,张丽娟.2型糖尿病患者合并非酒精性脂肪肝与胰岛素抵抗的相关性[J].热带医学杂志,2011,11(1):65-67. 被引量:23
  • 9Knobler H,Schattner A,Zhornicki T,et al. Fatty liver an addi- tional and treatable feature of the insulin resistance syndrome [J]. QJM,1999,92:73-79.
  • 10Malnick S D H, Beergabel M, Knobler H. Non-alcoholic fatty fiver a common manifestation of a metabolic disorder[J]. Q J Med,2003,96 .. 699-709.

二级参考文献23

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 2李伟,向红丁,戴为信,萧新华,夏维波,伍学焱,冯凯.2型糖尿病患者非酒精性脂肪肝及其相关因素的临床分析[J].中国糖尿病杂志,2006,14(1):35-36. 被引量:23
  • 3范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17.
  • 4Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies. Gastroenterology, 2003, 124:248-250.
  • 5Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
  • 6Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
  • 7Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
  • 8Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
  • 9Cortez-Pinto H,Camilo M E,Baptista A,et al.Nonalcoholic fatty liver:another feature of the metabolic syndrome? Clin Nutr,1999,18:353-358.
  • 10Howard BV.Lipoprotein metabolism in diabtes mellitus.J Lipid Res,1987,28:613 628.

共引文献888

同被引文献48

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部